( 02142.hk)
市盈率5.64市净率0.98市销率1.67股息率0.00%上市时间2020-12-10股价1.22港币 (-4.69% , 263.04万港币) 市值9.38亿港币总股本7.69亿上市至今年化投资收益率-42.69%
所属三级行业生物技术 (恒生) 市盈率-49.59市净率2.75市销率5.16股息率0.63%
备注 (1): 双击编辑备注
发表讨论

和铂医药-B(02142) - 历史董事名单

# 姓名职衔职位委任日期辞任日期
1COLLINSON Albert R.Independent Non Executive Director2023-07-13--
2戎一平Executive Director2022-05-05--
3陳小祥Executive Director2021-09-172022-05-05
4陳維維Non Executive Director2021-06-09--
5邱家賜Independent Non Executive Director2021-06-09--
6葉小平Independent Non Executive Director2020-11-30--
7陳維維Independent Non Executive Director - A/F2020-11-302021-06-09
8DESHPANDE Atul MukundExecutive Director2020-08-102021-04-25
9王俊峰Non Executive Director2018-03-212023-07-13
10廖邁菁Executive Director2018-01-182021-09-17
11KAMEN Robert IrwinIndependent Non Executive Director2016-12-07--
12裘育敏Non Executive Director2016-12-072023-07-13
13王勁松Executive DirectorChairman, CEO2016-07-20--